Analyst firms · Needham · RYTM
Needham RYTM price target and rating history
Rhythm Pharmaceuticals Inc. (RYTM) · Health Care
Needham rates Rhythm Pharmaceuticals Inc. (RYTM) Buy with a $25 price target, as of its latest action on Jun 17, 2022. It has published 3 rating actions on RYTM since February 2022, including 0 upgrades and 0 downgrades. Across 4 firms with a RYTM price target in the last 12 months, the median target is $134.50.
- Current rating
- Buy
- Price target
- $25
- Median target, all firms
- $134.50
- Actions on RYTM
- 3
Needham price target on RYTM
Every Needham rating on RYTM
- Jun 17, 2022
- Mar 2, 2022
- Feb 25, 2022
How other firms rate RYTM
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| William Blair | Outperform | Oct 16, 2026 | |
| Wolfe Research | Outperform | Sep 17, 2026 | |
| Leerink Partners | Outperform | $133 | Sep 14, 2026 |
| Deutsche Bank | Hold | $120 | Aug 28, 2026 |
| RBC Capital Markets | Outperform | $478 | Feb 19, 2026 |
| Citigroup | Buy | $136 | Nov 25, 2025 |
Questions about Needham and RYTM
- What is Needham's price target for RYTM?
- Needham's latest stated price target for Rhythm Pharmaceuticals Inc. (RYTM) is $25, from its action on Jun 17, 2022.
- What is Needham's rating on RYTM?
- Needham rates RYTM Buy, a bullish rating, as of Jun 17, 2022.
- When did Needham last change its view on RYTM?
- On Jun 17, 2022, Needham cuts its price target to $25 from $40, keeps Buy.
- How does Needham's RYTM target compare with other analysts?
- Across 4 firms with a RYTM price target in the last 12 months, the median target is $134.50.
More RYTM rating histories
All Needham ratingsRYTM news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.